Simultaneous assessment of short‐term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: An instrumental variable analysis
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective: To simultaneously assess the short‐term reduction in risk of gastrointestinal (GI) complications and increase in risk of acute myocardial infarction (MI) by celecoxib compared with rofecoxib and several nonselective nonsteroidal antiinflammatory drugs (NSAIDs) using instrumental variable analysis. Methods: A population of 49,711 Medicare beneficiaries ages 65 years and older who initiated nonselective NSAID or selective cyclooxygenase 2 inhibitor therapy between January 1, 1999, and December 31, 2002, was identified. The increase in risk of GI complications and MI within 180 days after initiation of NSAID (rofecoxib, diclofenac, ibuprofen, and naproxen compared with celecoxib) therapy was assessed using instrumental variable analysis. Results: Compared with nonselective NSAIDs, celecoxib reduced the risk of GI complications by 1.4 per 100 users but increased the risk of MI by 0.3 per 100 users. Rofecoxib decreased GI complications by 1.1 per 100 users and increased the risk of MI by 0.3 per 100 users. Using celecoxib as the reference exposure showed an increase in the MI risk for rofecoxib (risk difference [RD] 1.40, 95% confidence interval [95% CI] −0.20, 3.01) and diclofenac (RD 6.07, 95% CI −0.02, 12.15). The RD for naproxen as well as its upper 95% CI was the lowest of all NSAIDs (RD −0.30, 95% CI −2.74, 2.14) and there was no significant difference in GI complication rates among all NSAIDs. Conclusion: In this instrumental variable analysis, diclofenac and rofecoxib had the least favorable benefit–risk balance among NSAIDs in older adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of Causal Effects Using Instrumental Variables
Angrist, J. D., Imbens, G. W., & Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476902 · Cited by 4,230
The Estimation of Economic Relationships using Instrumental Variables
Sargan, J. D. (1958) · Econometrica · doi:10.2307/1907619 · Cited by 3,377
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Angrist, J. D., & Krueger, A. B. (2001) · Journal of Economic Perspectives · doi:10.1257/jep.15.4.69 · Cited by 2,355
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
An introduction to instrumental variables for epidemiologists
Greenland, S. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.4.722 · Cited by 1,156
Shah, B. R., Laupacis, A., Hux, J. E., & Austin, P. C. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.016 · Cited by 493
Research works printed but not linked: 36
- 10.1056/NEJM200011233432103 · DOI · Paper page
- 10.1016/S0140-6736(02)11131-7 · DOI · Paper page
- 10.1161/01.CIR.0000127578.21885.3E · DOI · Paper page
- 10.1016/S0140-6736(05)17864-7 · DOI · Paper page
- 10.1038/nrd1712 · doi:10.1038/nrd1712
- 10.1001/jama.284.10.1247 · DOI · Paper page
- 10.1056/NEJMoa050405 · DOI · Paper page
- 10.1016/S0140-6736(04)16894-3 · DOI · Paper page
- 10.1016/S0022-5223(03)00125-9 · DOI · Paper page
- 10.1056/NEJMoa050330 · DOI · Paper page
- 10.1002/art.21132 · DOI
- 10.1046/j.1525-1497.2002.11024.x · DOI
- 10.1126/science.310.5756.1890a · doi:10.1126/science.310.5756.1890a
- 10.1016/j.jclinepi.2004.10.012 · DOI · Paper page
- 10.1097/01.ede.0000147164.11879.b5 · DOI · Paper page
- Walker AM, 1996, Confounding by indication, Epidemiology, 7, 335
- Bowden RJ, 1984, Instrumental variables
- 10.1001/jama.1994.03520110039026 · DOI · Paper page
- 10.1016/S0140-6736(05)67786-0 · DOI · Paper page
- 10.1097/01.ede.0000193606.58671.c5 · DOI · Paper page
- 10.1016/j.amjmed.2003.08.025 · DOI
- 10.1016/j.jclinepi.2004.06.002 · DOI
- 10.1016/0895-4356(94)90170-8 · DOI · Paper page
- 10.1097/00001648-199601000-00018 · DOI
- 10.1016/j.ahj.2004.02.013 · DOI · Paper page
- 10.1016/S0895-4356(00)00259-6 · DOI
- 10.1093/oxfordjournals.aje.a117563 · DOI · Paper page
- 10.1097/01.ede.0000222026.42077.ee · DOI
- Greene WH, 1997, Econometric analysis, 740
- 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P · DOI · Paper page
- 10.1111/j.1572-0241.1998.00588.x · DOI · Paper page
- 10.1016/0895-4356(92)90133-8 · DOI · Paper page
- 10.1093/aje/154.9.854 · DOI · Paper page
- 10.1093/biomet/70.1.41 · DOI · Paper page
- 10.1093/aje/kwi106 · DOI · Paper page
- Rothman KJ, 1998, Modern epidemiology, 205
Cited by
Schneeweiss, S., Rassen, J. A., Glynn, R. J., Avorn, J., Mogun, H., & Brookhart, M. A. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a663cc · Cited by 1,128
Self-citationIbuprofen: pharmacology, efficacy and safety
Rainsford, K. D. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-0016-x · Cited by 667
Montenigro, P. H., Alosco, M. L., Martin, B. M., Daneshvar, D. H., Mez, J., Chaisson, C. E., Nowinski, C. J., Au, R., McKee, A. C., Cantu, R. C., et al. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2016.4413 · Cited by 564
One‐to‐many propensity score matching in cohort studies
Rassen, J. A., Shelat, A. A., Myers, J., Glynn, R. J., Rothman, K. J., & Schneeweiss, S. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3263 · Cited by 510
Self-citationSchneeweiss, S., Setoguchi, S., Brookhart, A., Dormuth, C., & Wang, P. S. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061250 · Cited by 366
Self-citationAprotinin during Coronary-Artery Bypass Grafting and Risk of Death
Schneeweiss, S., Seeger, J. D., Landon, J., & Walker, A. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707571 · Cited by 357
Self-citationPisoni, R. L., Arrington, C. J., Albert, J. M., Ethier, J., Kimata, N., Krishnan, M., Rayner, H. C., Saito, A., Sands, J. J., Saran, R., et al. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.10.043 · Cited by 354
Castellsague, J., Riera-Guardia, N., Calingaert, B., Varas-Lorenzo, C., Fourrier-Reglat, A., Nicotra, F., Sturkenboom, M., Perez-Gutthann, S., & Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project (2012) · Drug Safety · doi:10.1007/bf03261999 · Cited by 341
Instrumental variable methods in comparative safety and effectiveness research
Brookhart, M. A., Rassen, J. A., & Schneeweiss, S. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1908 · Cited by 332
Self-citationMetrics for covariate balance in cohort studies of causal effects
Franklin, J. M., Rassen, J. A., Ackermann, D., Bartels, D. B., & Schneeweiss, S. (2014) · Statistics in Medicine · doi:10.1002/sim.6058 · Cited by 312
Self-citationIndividual NSAIDs and Upper Gastrointestinal Complications
Castellsagué, J., Riera‐Guàrdia, N., Calingaert, B., Varas‐Lorenzo, C., Fourrier‐Réglat, A., Nicotra, F., Sturkenboom, M., & Perez‐Gutthann, S. (2012) · Drug Safety · doi:10.2165/11633470-000000000-00000 · Cited by 309
Rassen, J. A., Brookhart, M. A., Glynn, R. J., Mittleman, M. A., & Schneeweiss, S. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.12.005 · Cited by 164
Self-citationDreyer, N. A., Velentgas, P., Westrich, K., & Dubois, R. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.3.301 · Cited by 107
Metadata
- Authors
- Schneeweiss, S., Solomon, D. H., Wang, P. S., Rassen, J., & Brookhart, M. A.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2006-10-30
- Volume
- 54
- Issue
- 11
- Pages
- 3390-3398
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2128939361
- Cited by
- 93
- References
- 7
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.